BNP Paribas Financial Markets’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-19,061
Closed -$115K 3794
2019
Q4
$115K Sell
19,061
-298,615
-94% -$1.8M ﹤0.01% 2576
2019
Q3
$1.14M Buy
317,676
+299,615
+1,659% +$1.08M ﹤0.01% 1274
2019
Q2
$48.4K Sell
18,061
-13,383
-43% -$35.9K ﹤0.01% 2820
2019
Q1
$93.1K Buy
31,444
+28,404
+934% +$84.1K ﹤0.01% 2582
2018
Q4
$4.83K Sell
3,040
-4,682
-61% -$7.45K ﹤0.01% 2924
2018
Q3
$28.4K Buy
7,722
+595
+8% +$2.19K ﹤0.01% 2609
2018
Q2
$20.2K Sell
7,127
-23,582
-77% -$66.7K ﹤0.01% 2850
2018
Q1
$114K Buy
30,709
+4,883
+19% +$18.1K ﹤0.01% 2546
2017
Q4
$74.4K Buy
25,826
+13,305
+106% +$38.3K ﹤0.01% 2806
2017
Q3
$56.2K Sell
12,521
-3,920
-24% -$17.6K ﹤0.01% 2650
2017
Q2
$75.5K Buy
16,441
+14,389
+701% +$66K ﹤0.01% 2523
2017
Q1
$8.64K Sell
2,052
-6,092
-75% -$25.6K ﹤0.01% 2663
2016
Q4
$33.6K Sell
8,144
-1,548
-16% -$6.39K ﹤0.01% 2528
2016
Q3
$78.5K Buy
9,692
+5,137
+113% +$41.6K ﹤0.01% 2218
2016
Q2
$35.5K Buy
+4,555
New +$35.5K ﹤0.01% 2406
2016
Q1
Sell
-25,324
Closed -$273K 3302
2015
Q4
$273K Sell
25,324
-18,983
-43% -$205K ﹤0.01% 1718
2015
Q3
$306K Buy
44,307
+24,527
+124% +$169K ﹤0.01% 1676
2015
Q2
$175K Buy
19,780
+7,088
+56% +$62.8K ﹤0.01% 1774
2015
Q1
$125K Buy
12,692
+7,692
+154% +$75.8K ﹤0.01% 1683
2014
Q4
$61.3K Sell
5,000
-13,204
-73% -$162K ﹤0.01% 1643
2014
Q3
$182K Sell
18,204
-2,218
-11% -$22.1K ﹤0.01% 1604
2014
Q2
$155K Buy
+20,422
New +$155K ﹤0.01% 1553
2014
Q1
Sell
-1,252
Closed -$4.16K 3380
2013
Q4
$4.16K Sell
1,252
-25,032
-95% -$83.1K ﹤0.01% 2727
2013
Q3
$79.4K Sell
26,284
-9,164
-26% -$27.7K ﹤0.01% 2131
2013
Q2
$290K Buy
+35,448
New +$290K ﹤0.01% 1744